Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated

PharmaSourcesJanuary 23, 2023

Tag: Clinical trials , SonoTran , OxSonics Therapeutics , Irinotecan , Cetuximab

PharmaSources Customer Service